当前位置:首页 - 行情中心 - 康辰药业(603590) - 财务分析 - 现金流量表

康辰药业

(603590)

  

流通市值:79.90亿  总市值:80.48亿
流通股本:1.58亿   总股本:1.59亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金681,399,880.97395,655,319.72174,532,864.04863,943,830.85
  收到的税费返还---16,585,029.21
  收到其他与经营活动有关的现金24,619,689.7911,447,932.941,170,403.0235,307,501.34
  经营活动现金流入小计706,019,570.76407,103,252.66175,703,267.06915,836,361.4
  购买商品、接受劳务支付的现金45,825,704.8831,440,009.1219,442,164.467,324,089.6
  支付给职工以及为职工支付的现金222,821,457.01153,431,689.2885,383,454.82226,090,521.73
  支付的各项税费58,129,441.7531,957,530.686,648,626.6228,119,661.95
  支付其他与经营活动有关的现金295,343,717.02201,951,157.395,741,228.55422,056,909.63
  经营活动现金流出小计622,120,320.66418,780,386.38207,215,474.39743,591,182.91
  经营活动产生的现金流量净额83,899,250.1-11,677,133.72-31,512,207.33172,245,178.49
二、投资活动产生的现金流量:
  收回投资收到的现金1,001,144,814.09820,000,000170,000,0001,280,762,198.32
  取得投资收益收到的现金12,288,287.3411,419,895.411,164,986.2919,827,717.15
  处置固定资产、无形资产和其他长期资产收回的现金净额607,970155,000-30,395
  投资活动现金流入小计1,014,041,071.43831,574,895.41171,164,986.291,300,620,310.47
  购建固定资产、无形资产和其他长期资产支付的现金44,853,149.4827,583,874.1422,522,406.22104,020,597.18
  投资支付的现金900,500,000560,000,000110,000,0001,395,000,000
  投资活动现金流出小计945,353,149.48587,583,874.14132,522,406.221,499,020,597.18
  投资活动产生的现金流量净额68,687,921.95243,991,021.2738,642,580.07-198,400,286.71
三、筹资活动产生的现金流量:
  取得借款收到的现金256,505,696.4784,705,761.6239,659,140217,549,110.14
  收到其他与筹资活动有关的现金---9,683,504.8
  筹资活动现金流入小计256,505,696.4784,705,761.6239,659,140227,232,614.94
  偿还债务支付的现金179,434,554.9935,995,679.1421,153,982.14171,513,337.58
  分配股利、利润或偿付利息支付的现金100,432,320.198,533,179.921,436,169.3553,492,097.04
  支付其他与筹资活动有关的现金11,339,121.986,161,508.312,046,661.8110,498,487.72
  筹资活动现金流出小计291,205,997.07140,690,367.3724,636,813.3235,503,922.34
  筹资活动产生的现金流量净额-34,700,300.6-55,984,605.7515,022,326.7-8,271,307.4
四、汇率变动对现金及现金等价物的影响-1,701.257,729.741,218.83-2,816,383.01
五、现金及现金等价物净增加额117,885,170.2176,337,011.5422,153,918.27-37,242,798.63
  加:期初现金及现金等价物余额189,977,701.84189,977,701.84189,977,701.84227,220,500.47
  期末现金及现金等价物余额307,862,872.04366,314,713.38212,131,620.11189,977,701.84
补充资料:
  净利润-96,334,639.19-21,530,544.55
  资产减值准备---105,547,311.98
  固定资产和投资性房地产折旧-10,238,902.29-21,731,837.09
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-10,238,902.29-21,731,837.09
  无形资产摊销-5,104,167.39-9,506,245.02
  长期待摊费用摊销-104,582.85-525,652.42
  处置固定资产、无形资产和其他长期资产的损失--130,668.15-7,331.58
  固定资产报废损失---25,320.95
  公允价值变动损失--379,689.56-486,686.56
  财务费用-3,317,561.87-8,971,882.16
  投资损失--10,015,947.42--18,142,328.06
  递延所得税-5,425,652.75-6,457,429.54
  其中:递延所得税资产减少-5,658,086.96-4,806,844.47
    递延所得税负债增加--232,434.21-1,650,585.07
  存货的减少-2,862,145.22--24,051,503.5
  经营性应收项目的减少--89,917,750.62-32,671,622.51
  经营性应付项目的增加--52,540,620.67--26,552,281.64
  其他-4,099,873.13-21,884,494.7
  现金的期末余额-366,314,713.38-189,977,701.84
  减:现金的期初余额-189,977,701.84-227,220,500.47
  现金及现金等价物的净增加额-176,337,011.54--37,242,798.63
公告日期2025-10-302025-08-282025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑